| Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV MN Kararoudi, S Likhite, E Elmas, K Yamamoto, M Schwartz, K Sorathia, ... Cell Reports Methods 2 (6), 2022 | 28 | 2022 |
| CD33 targeting primary CAR-NK cells generated by CRISPR mediated gene insertion show enhanced anti-AML activity MN Kararoudi, S Likhite, E Elmas, M Schwartz, K Sorathia, K Yamamoto, ... Blood 136, 3, 2020 | 17 | 2020 |
| Evaluation of serum-free media formulations in feeder cell–stimulated expansion of natural killer cells JE Moseman, JA Foltz, K Sorathia, EL Heipertz, DA Lee Cytotherapy 22 (6), 322-328, 2020 | 17 | 2020 |
| CRISPR gene editing of human primary NK and T cells for cancer immunotherapy E Elmas, N Saljoughian, M de Souza Fernandes Pereira, BP Tullius, ... Frontiers in Oncology 12, 834002, 2022 | 16 | 2022 |
| CRISPR-targeted CAR gene insertion using Cas9/RNP and AAV6 enhances anti-AML activity of primary NK cells MN Kararoudi, S Likhite, E Elmas, K Yamamoto, M Schwartz, K Sorathia, ... bioRxiv, 2021.03. 17.435886, 2021 | 10 | 2021 |
| A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models WK Chan, J Williams, K Sorathia, B Pray, K Abusaleh, Z Bian, A Sharma, ... Experimental Hematology & Oncology 12 (1), 79, 2023 | 2 | 2023 |
| Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism MSF Pereira, K Sorathia, Y Sezgin, A Thakkar, C Maguire, PL Collins, ... Cancers 15 (3), 705, 2023 | 1 | 2023 |
| CRISPR-Targeted CAR Gene Insertion Using Cas9/RNP and AAV6 Enhances Anti-AML Activity of Primary NK Cells S Likhite, E Elmas, K Yamamoto, M Schwartz, K Sorathia, M Pereira, ... | | 2021 |
| SOLUBLE IL-2 HAS A DOSE-DEPENDENT EFFECT ON NATURAL KILLER CELL EXPANSION ON A MEMBRANE-BOUND IL-21 EXPRESSING FEEDER CELL PLATFORM BP Tullius, A Thakkar, K Sorathia, A Campbell, P Trikha, DA Lee PEDIATRIC BLOOD & CANCER 67, S229-S229, 2020 | | 2020 |
| Deep functional and phenotypic characterization* of expanded and cryopreserved NK cells establishes consistent product identity across GMP and clinical-scale manufacturing … P Trikha, JR Schafer, L O’Donnell, H Bradbury, SO Ciurea, ... | | |
